Progesterone receptor (PR) is an estrogen-stimulated gene which has a CpG island that is heavily methylated in a signi®cant fraction of estrogen receptor (ER)-negative/PR-negative human breast cancers and cell lines, including MDA-MB-231 cells. Treatment of MDA-MB-231 cells with the demethylating agent, 5-aza-2'-deoxycytidine (deoxyC) led to demethylation and expression of ER and PR. However, simultaneous treatment with antiestrogen prevented PR transcription, suggesting that demethylation of PR alone is not sucient to reactivate the PR gene. To examine the eects of ER on the methylation status of the PR CpG island, we stably transfected MDA-MB-231 cells with an inducible expression vector for ER. Surprisingly, in two cell clones, we found that induction of PR gene expression by ligand-bound ER does not require demethylation of the PR CpG island. In contrast, induction of PR transcription was inhibited by blocking the interaction of ER with SRC-1A, a coactivator of ER function. For the ®rst time, we show that a transcription factor with the potential to remodel heterochromatin can activate gene expression without altering the methylation status of the CpG island. These results raise the possibility that demethylation and histone acetylation are distinct but complementary mechanisms for destabilizing heterochromatin and activating transcription.
Introduction
Progesterone receptor (PR) is a transcription factor of the steroid hormone receptor superfamily. The human PR gene encodes at least two isoforms, hPR A (79 kD) and hPR B (109 kD), which dier in both their amino terminal sequences and biological activities (Kastner et al., 1990) . Of note, the hPR B transcript is preferentially induced by estrogen receptor a (ER) while the hPR A is not (Graham et al., 1995) . Since ligand-bound ER is a major transcriptional activator of hPR B gene expression, the presence of PR in a cell is indicative of functional ER. Interestingly, it was recently shown that ER function is enhanced by its association with the coactivators SRC-1A, CREB binding protein (CPB) and p/CAF that all have intrinsic histone acetyltransferase (HAT) activity and play a role in remodeling the chromatin of estrogen responsive genes Smith et al., 1996; Korzus et al., 1998; Beato et al., 1996) .
In breast cancer, the absence of these two steroid hormone receptors is associated with resistance to endocrine therapies (McGuire, 1978) . Since 60% of mammary carcinomas lack PR, mechanisms responsible for regulation of PR gene expression are critical areas of study. Lack of gene expression may involve changes in levels of transcription factors or epigenetic alterations of cis-acting regulatory sequences, including DNA methylation.
Aberrant methylation of cytosine-guanine rich areas called CpG islands in the 5' regulatory region and ®rst exon of genes is a potential mechanism for the loss of PR gene expression (Bird, 1986) . In normal adult tissues, CpG islands are unmethylated with the exception of the transcriptionally silent genes on the inactive X chromosome and parentally imprinted genes (Mohandas et al., 1981; Li et al., 1993) . However, aberrant hypermethylation of CpG islands throughout the eukaryotic genome is an early event in the progression of human cancer (Baylin et al., 1991) . Speci®cally, hypermethylation at the 5' region of tumor suppressor genes such as p16 and Rb as well as the metastasis suppressor gene E-cadherin, is correlated with lack of expression of these genes in various human cancers (Herman et al., 1995; Ohtani-Fujita et al., 1993; Yoshiura et al., 1995) . Methylation of CpG islands has been shown to directly inhibit the binding of certain transcription factors to their recognition sites in vitro (Comb and Goodman, 1990; Iguchi-Ariga and Schaner, 1989; Klempnauer, 1993; Prendergast and Zi, 1991) . In addition, histone H1, as well as other proteins that may act as global transcriptional repressors by promoting heterochromatinization, preferentially bind to methylated DNA in vitro (Levine et al., 1993; Lewis et al., 1992; Meehan et al., 1989; . These results suggest that in vivo CpG island methylation can inhibit transcription factor binding to speci®c DNA sites and/or may cause a conformational change in chromatin that prevents transcription.
Previously, we identi®ed CpG islands in the 5' region of the ER and PR genes (Ottaviano et al., 1994; Lapidus et al., 1996) . Aberrant methylation of these islands is associated with lack of ER and PR gene expression in a signi®cant fraction of primary breast cancers (Lapidus et al., 1996) . Treatment of the ERnegative/PR-negative human breast cancer cell line, MDA-MB-231, with a demethylating agent led to production of PR protein, suggesting that aberrant methylation plays a role in the transcriptional inactivation of PR (Ferguson et al., 1995) . Here we investigate the possible mechanisms by which methylation could in¯uence PR gene expression using the MDA-MB-231 cells as a model for PR-negative breast cancers. Our data suggest that ER association with HATs and/or interaction with the general transcription machinery can overcome methylation-associated heterochromatinization at the PR CpG island leading to activation of the PR gene in MDA-MB-231 breast cancer cells.
Results
DeoxyC-mediated reactivation of PR gene expression is associated with demethylation at the PR CpG island but is blocked by antiestrogen
We chose to study the regulation of PR gene expression by DNA methylation in the ER-negative/ PR-negative cell line, MDA-MB-231, because these cells lack PR mRNA as demonstrated by reverse transcriptase-PCR (Ferguson et al., 1995) . This suggests that the absence of PR is a consequence of loss of transcription. We have previously shown that the PR gene has a CpG dinucleotide dense region within its ®rst exon ( Figure 1a , Lapidus et al., 1996) , which is methylated in 40% of PR-negative primary breast cancers. We assessed whether the lack of PR gene expression in MDA-MB-231 cells was associated with hypermethylation of exon one as we have found in primary PR-negative tumors. In order to analyse the methylation status of the PR CpG island, genomic DNA was ®rst digested with the methylation-insensitive enzyme, EcoRI, and then with one of six methylation-sensitive enzymes, EagI, SacII, BssHII, SmaI, HhaI or HpaII. The resultant DNA fragments were resolved by gel electrophoresis and analysed by Southern blot using the genomic probe shown in Figure 1a . Digestion of DNA with EcoRI alone produces a 5.6 kb DNA fragment. If the PR CpG island is methylated, then simultaneous digestion with EcoRI and one of the methylation-sensitive restriction enzymes will yield a 5.6 kb DNA fragment because the DNA is protected from digestion. However, if the CpG island is unmethylated, digestion with a methylationsensitive enzyme will produce smaller molecular weight DNA fragments of 3.6, 2.8 or 3.4 kb for EagI, SacII or BssHII, respectively.
As indicated by the Southern blot analysis, digestion of DNA from the ER-positive cell line, MCF-7, with each of the ®ve methylation-sensitive enzymes produced smaller molecular weight fragments characteristic of unmethylated DNA (Figure 1b and data not shown). In contrast, digestion of DNA from MDA-MB-231 cells with EagI, SacII, BssHII, SmaI or HhaI yielded a single 5.6 kb DNA fragment indicative of complete methylation at these sites ( Figure 1b and data not shown). These results indicate that the lack of PR gene expression is associated with a high density of methylation at exon one of the PR CpG island of MDA-MB-231 cells.
Previously we showed that treatment of MDA-MB-231 cells with the demethylating agent, deoxyC, led to reactivation of both ER and PR gene expression (Ferguson et al., 1995) . However, the eect of deoxyC on the methylation status of PR CpG island was not examined. Therefore, both MCF-7 and MDA-MB-231 cells were grown for 7 days in the presence or absence of 0.75 mM deoxyC in medium that contained 5% fetal calf serum and phenol red. Changes in the methylation status of genomic DNA from these cells and associated induction of ER and PR proteins were monitored by Southern and Western blot analysis, respectively. As expected, there was no change in the methylation status of the PR CpG island in deoxyC-treated MCF-7 cells (Figure 2a ). In contrast, DNA from treated MDA-MB-231 cells displayed partial demethylation at the EagI and SacII sites within the PR CpG island as demonstrated by the presence of smaller DNA fragments at 3.6 and 2.8 kb respectively (Figure 2a ). The partial demethylation was associated with induction of PR protein, suggesting that deoxyC-induced demethylation plays a role in reactivating PR gene expression in MDA-MB-231 cells (Figure 2b ).
DeoxyC-mediated reactivation of PR may be a direct result of demethylation and reactivation of its transcriptional activator, ER. In order to determine the importance of ER in deoxyC-induced PR transcription, MDA-MB-231 cells were simultaneously treated with deoxyC, which leads to demethylation and reactivation of both ER and PR, and the pure antiestrogen, ICI 182,780, that blocks ER binding to cis-acting sites. The concentration of antiestrogen used, 400 nM, was sucient to inhibit the expression of two endogenous, estrogen-regulated genes, pS2 and PR, in MCF-7 cells grown in medium containing 5% fetal calf serum and phenol red (Figure 2b and data not shown). Southern Lapidus et al. (1996) . The 1.5 kb BamHI DNA fragment used to probe Southern blots and CG frequency within exon one are shown. Digestion of DNA with the methylationinsensitive enzyme EcoRI (R1) alone produces a 5.6 kb DNA fragment. The methylation-sensitive restriction enzymes, EagI (E; black diamond), SacII (S; black triangle), BssHII (B; black star), SmaI (black circle) and HhaI (line) were used to test the methylation status of PR DNA. The sizes of the DNA fragments predicted when unmethylated DNA is digested with EcoRI and the methylation-sensitive restriction enzymes, EagI, SacII or BssHII are shown. (b) Southern blot analysis of DNA from the PR-positive cell line, MCF-7, and the PR-negative cell line, MDA-MB-231. Absence of methylation at the methylationsensitive restriction sites results in bands that are less than 5.6 kb in size (3.6 kb, 3.4 kb, 2.8 kb), whereas methylation of these sites results in a band equal in size to the 5.6 kb EcoRI fragment blot analysis was used to examine the methylation status of DNA from cells treated with the combination of the two drugs ( Figure 2a) . Notably, 400 nM ICI 182,780 had no eect on the ability of deoxyC to demethylate the EagI and SacII sites within the PR gene CpG island in MDA-MB-231 cells (Figure 2a) . Western blot analysis demonstrated that deoxyCtreated MDA-MB-231 cells produced PR protein, while cells treated with a combination of deoxyC and ICI 182,780 did not (Figure 2b ). These data indicate that deoxyC-mediated induction of ER is an important step in reactivation of PR transcription. More importantly, the results suggested that demethylation alone was not sucient for PR gene expression in MDA-MB-231 cells.
Demethylation of the PR CpG island is not required for reactivation of PR gene expression
Our results indicated that deoxyC-mediated reactivation of PR was highly dependent on ER, as shown by the studies using a combination of deoxyC and antiestrogen. Therefore, we examined the eect of exogenous ER expression on the methylation status of the PR CpG island and PR gene expression. In particular, it was of interest to determine whether demethylation of the PR CpG island is required for reactivation of PR transcription. Two stable MDA-MB-231 cell clones, containing the ER cDNA under the control of a heavy metal-inducible promoter, were used to examine changes in the methylation status of the PR CpG island in the absence and presence of exogenous ER. These clones, 231WT.12 and 231WT.17, were grown in medium containing 5% fetal calf serum and phenol red and treated with 100 mM ZnSO 4 . This concentration of zinc had no eect on the growth or morphology of either the parental MDA-MB-231 cells or cells stably transfected with antisense ER cDNA under control of the same promoter (data not shown). Cells treated with the heavy metal for 1 or 4 days were examined for changes in protein synthesis and methylation status of DNA. Within 24 h of zinc treatment, both ER and PR proteins were induced in both cell clones and the amount of ER protein produced in the inducible clones was roughly equivalent to the level of endogenous protein in the ER-positive MCF-7 cells ( Figure 3a) . Next, changes in the methylation status of the PR CpG island during zinc treatment were monitored by digesting DNA from these two cell clones with EcoRI and each of the three methylationsensitive restriction enzymes, EagI, SacII and BssHII and analysing the resultant DNA fragments by Southern blot analysis. During the course of zinc treatment, DNA from both 231WT.12 and 231 WT.17 remains fully methylated at all of the methylationsensitive sites tested within the PR CpG island as indicated by the constant presence of the 5.6 kb DNA fragment (Figure 3b ). The induction of ER leads to PR gene expression in two independent MDA-MB-231 clones despite extensive methylation at the PR CpG island which is maintained for at least 4 days after initiation of transcription. These data indicate that ligand-bound ER alone was sucient to reactivate PR transcription in MDA-MB-231 cells. These results suggest that demethylation of the PR gene CpG island is not a necessary prerequisite for PR gene expression in MDA-MB-231 cells and that the ability of ER to activate PR gene expression is not aected by the maintenance of methylation at the PR CpG island.
ER association with the coactivator SRC-1A is required for induction of PR gene expression in MDA-MB-231 cells
Thus far, our results demonstrated that ER was both necessary and sucient for PR gene expression in MDA-MB-231 cells. ER may be able to initiate transcription by interacting with proteins that play a role in chromatin remodeling or initiation of transcription. Recently, it was demonstrated that estrogen-bound ER associates with coactivators such as SRC-1A that possess intrinsic histone acetyltransferase (HAT) activity and recruits other HATs including CBP and p/CAF to chromatin (Onate et al., 1995; Spencer et al., 1997; Smith et al., 1996; Jenster et al., 1997) . In addition, CBP links steroid hormone receptors to components of the basal transcription machinery including RNA polymerase II, TATA-binding protein, TFIIB and TFIID (Kee et al., 1996; Abraham et al., 1993; Xing et al., 1995) . Consequently, we postulated that ER may direct HATs and general transcription factors to the PR gene, leading to reorganization of the chromatin associated with the PR CpG island. Therefore, we examined whether ER association with SRC-1A was required for induction of PR transcription in MDA-MB-231 cells. MDA-MB-231 cells were transiently transfected with pCMV-ER, an expression vector for ER, in the presence or absence of SRC-1 (.8). SRC-1 (.8) is a dominant negative inhibitor of SRC-1A which interferes with the interaction of ER and SRC-1A, and leads to a partial inhibition of steroid hormone-responsive reporter gene activity as assayed in transiently transfected cells (Onate et al., 1995) . Three independent experiments were performed in triplicate and results from one representative experiment are shown in Figure 4 . Compared to the vector control, PR protein levels decreased by an average of 3.8-fold in the presence of SRC-1 (.8). These results demonstrate the importance of the interaction between ER and SRC-1A in activation of PR gene expression in MDA-MB-231 cells and support a role for the recruitment of HATs and general transcription factors in remodeling methylation-associated CpG island heterochromatin. 
Discussion
The two steroid hormone receptors ER and PR are critical determinants in the development and progression of breast cancer as well as the treatment and outcome of breast cancer patients (McGuire, 1978) . Tumors that express ER and PR are generally responsive to hormonal therapies designed to remove circulating estrogens or block the interaction of steroid hormones with their receptors. Breast carcinomas that lack these two receptors are rarely responsive to these treatments (McGuire, 1978) . Previously, we found that a signi®cant fraction of tumors that lacked both ER and PR were methylated at the 5' regions of the two genes, implicating one mechanism for loss of their gene expression in some tumors (Lapidus et al., 1996) .
Our goal was to examine the mechanism by which methylation suppresses PR gene expression in MDA-MB-231 cells, an established human breast cancer cell line that represents a model for ER-negative/PRnegative tumors whose DNA is hypermethylated. As expected, we demonstrate that treatment of MDA-MB-231 cells with the demethylating agent, deoxyC, leads to partial demethylation and re-expression of the PR gene, which further implicates hypermethylation as a mechanism for PR gene inactivity.
Presently, there are two proposed mechanisms that explain how methylation may silence gene expression. The ®rst mechanism suggests that methylation may directly block transcription factor access to its recognition sequence. Using in vitro binding analyses, it has been well documented by others that methylation of the recognition sites for several transcription factors, including c-Myc, c-Myb, CREB and AP-2, either greatly reduces or prevents their ability to bind DNA, which presumably leads to transcriptional attenuation (Comb and Goodman, 1990; Iguchi-Ariga and Schaner, 1989; Klempnauer, 1993; Prendergast and Zi, 1991) . Our preliminary ®ndings suggest that there are no estrogen responsive elements located within the PR gene CpG island (data not shown). Another mechanism that may be involved in PR gene silencing in MDA-MB-231 cells is heterochromatinization at the PR CpG island. Several studies have suggested that dense DNA methylation promotes the binding of histone H1 or methyl-speci®c binding proteins that have a wide range of anity and speci®city for methylated DNA (Levine et al., 1993; Lewis et al., 1992; Meehan et al., 1989; . These proteins may either compete with transcriptional activators for binding to a speci®c cis-acting site or help to stabilize a condensed chromatin structure that renders the DNA inaccessible to transcription factors (Kass et al., 1993) .
Unexpectedly, our experiments using MDA-MB-231 cells stably transfected with pSAR-MT-ERsense-neo demonstrate that ER activates PR transcription despite PR CpG island methylation. This raises the question of what role methylation plays in controling PR gene expression. The ®rst exon of the hPR B gene contains a one kilobase pair region with a high density of CpG dinucleotides of which at least 27 sites are completely methylated in MDA-MB-231 cells (unpublished results). This CpG dense region is located hundreds of base pairs downstream of the transcriptional start site for hPR B . Therefore, one possibility is that methylated sequences within the PR CpG island are too far downstream to in¯uence PR gene expression. However, numerous studies have shown that the ability of methylation to repress gene expression is highly dependent on the length and methyl CpG density of a particular promoter, but less dependent on the position and distance of the methylated DNA sequences from the transcriptional initiation site (Hsieh, 1994; Kass et al., 1993; Hsieh, 1997; Rideout III et al., 1994) . Speci®cally, it was found that methylation of nonpromoter DNA sequences approximately two kilobase pairs from the transcription initiation site decreased gene expression to the same extent as methylation of the promoter itself and was associated with inactive chromatin in both the nonpromoter and promoter sequences (Kass et al., 1993) .
Another possibility is that methylation of speci®c sites within the PR CpG island that were not evaluated by the methylation-sensitive restriction enzyme analysis is involved in repression of PR transcription. In order to rule out this possibility, a more sensitive technique like methylation-speci®c PCR that encompasses more CpG sites would have to be developed (Herman et al., 1994) . However, it is important to note that, unlike ER-mediated reactivation of PR, deoxyC treatment led to obvious demethylation of all of the sites examined by methylation-sensitive restriction enzyme analysis, suggesting that the critical sites were examined.
Lastly, we favor the possibility that methylation participates in silencing PR gene expression but ER can overcome methylation-mediated chromatin condensation of DNA without the requirement for demethylation of the PR gene CpG island. Steroid hormone receptors are known to interact with proteins directly involved in transcription as well as chromatin structure (Beato et al., 1996) . Importantly, it was recently shown that there is a strict requirement for the HAT activity of p/CAF in transcriptional activation by nuclear receptors (Korzus et al., 1998) . Since our data show that the SRC-1A is important for ER-mediated induction of PR gene expression, we propose that ER association with histone acetyltransferases such as CBP and p/CAF is sucient to alter the chromatin conformation around the transcriptional start site of the PR gene. In combination with basal transcription factors such as TATA-binding protein, these interactions would allow access of other transcription factors and RNA polymerase II to the DNA leading to initiation of transcription.
Our ®ndings demonstrate that there is a consistent correlation between hypermethylation of the PR CpG island and absence of PR gene expression in PRnegative breast cancer cells. In addition, the results suggest that ER-mediated chromatin remodeling is sucient to activate PR gene expression. To our knowledge, this is the ®rst demonstration that reactivation of a gene that is methylated in a cancer cell is shown to be independent of demethylation. Although DNA demethylation and histone acetylation both in¯uence chromatin structure, our studies suggest the possibility that histone acetylation is the dominant process in reactivation of PR transcription.
Materials and methods

Cell culture and reagents
MDA-MB-231, MCF-7 and T47D cells were maintained in phenol red-containing DMEM with 5% fetal calf serum. DeoxyC (Sigma) was freshly prepared in distilled water and cells were treated with 0.75 mM for 7 days with supplementation at 4 days. ICI 182,780 (a gift of A Wakeling, Zeneca Pharmaceuticals, Maccles®eld, England) was prepared as a 2 mM stock in absolute ethanol and appropriate concentrations were added fresh to the media every 2 days. MDA-MB-231.12 and MDA-MB-231.17 cell lines were maintained in medium containing 500 mg/ml G418 (Gibco). The derivation of these two sublines is described below. Genomic DNA and cellular proteins were extracted from cells using standard protocols.
Southern and Western blot analysis
For the analysis of PR CpG island methylation status, 5 or 7.5 mg DNA from treated and untreated cells was digested with 10 units/mg EcoRI (a methylation-insensitive restriction enzyme) and one of the following methylationsensitive enzymes, 15 units/mg EagI, 15 units/mg SacII, 15 units/mg BssHII, 15 units/mg HhaI or 15 units/mg SmaI and subjected to electrophoresis in a 1% agarose gel. Southern and Western blot analyses were performed as described previously (Ferguson et al., 1995; Lapidus et al., 1996) . As a control for partial enzymatic digestion in Southern blot analysis, all ®lters were stripped and rehybridized with a 658 bp c-abl-speci®c DNA probe.
Plasmid DNAs
The plasmids pAB and pAB-SRC-1 (.8) (gifts of BW O'Malley, Onate et al., 1995) and pSAR-MT (a gift of B Vogelstein, Morin et al., 1996) were previously described. pAB-SRC-1 (.8) contains an amino terminal truncated SRC-1A cDNA that acts as a dominant negative inhibitor of SRC-1A under control of the rous sarcoma virus promoter. pSAR-MT contains a mutant metallothionine promoter and scaold attachment region (SAR) sequences surrounding a cloning site for inducible gene expression.
The construction of pCMV-ER and pSAR-MT-ERsenseneo is described as follows. A 1.5 kb DNA fragment containing the SV40 early promoter driving the neomycin resistance gene was blunt-ended and cloned into the AatII site of pSAR-MT, which was also blunt-ended, to create pSAR-MT-neo. To generate an ER cDNA fragment with the appropriate restriction enzyme sites at its ends, the 1.8 kb EcoRI cDNA was excised from pCMVERneo (a gift of VC Jordan, Jiang and Jordan, 1992) and cloned into the EcoRI site of pBluescript KS7. Next, the cDNA fragment was removed from this plasmid by digestion with SpeI and EcoRV and cloned between the XbaI and EcoRV sites of pcDNA3 (Invitrogen). This plasmid is named pCMV-ER. Finally, the 1.8 kb ER cDNA fragment was removed from pCMV-ER with BamHI and cloned into the unique BamHI site of pSAR-MT-neo. A construct containing the ER cDNA fragment in the sense orientation with respect to the metallothionine promoter was named pSAR-MT-ERsenseneo.
Transient transfections
Cells were seeded at approximately 4610 5 cells in 60 mm dishes. Twenty-four hours later, cells were transfected with cesium chloride gradient-puri®ed plasmid DNAs using lipofectamine (Gibco ± BRL). Each 60 mm dish of MDA-MB-231 cells was transfected with 5 mg pCMV-ER and either 5 mg of pAB-SRC-1 (.8) or the pAB vector (negative control) (Onate et al., 1995) . At 48 h post-transfection, proteins were extracted from cells and quantitatively analysed for levels of ER and PR proteins by Western blot analysis as described above using the polyclonal antibodies HC-20 (ER) and C19 (PR) (Santa Cruz Biotechnology). Three independent experiments were performed in triplicate. The amount of PR protein relative to ER protein was quantitated using a phosphorimager. Results from one representative experiment is shown.
Creation of cell lines expressing an inducible ER cDNA
MDA-MB-231 cells at approximately 25% con¯uence in 100 mm diameter dishes were transfected with 10 mg of pSAR-MT-ERsense-neo by the calcium phosphate method. At 48 h post-transfection, cells were harvested and reseeded at low density in medium containing 1 mg/ml Geneticin (G418, Gibco). After 3 weeks, individual G418-resistant cell clones were isolated and expanded. Clonal cell populations were tested for their ability to induce ER protein in response to 100 mM ZnSO 4 by Western blot analysis as described above. Two clones, MDA-MB-231.12 and MDA-MB-231.17, that stably express ER when induced with zinc, were selected randomly for further study.
